These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29741592)

  • 21. Twelve-Year Longitudinal Trends in Trachoma Prevalence among Children Aged 1-9 Years in Amhara, Ethiopia, 2007-2019.
    Sata E; Nute AW; Astale T; Gessese D; Ayele Z; Zerihun M; Chernet A; Melak B; Jensen KA; Haile M; Zeru T; Beyen M; Dawed AA; Seife F; Tadesse Z; Callahan EK; Ngondi J; Nash SD
    Am J Trop Med Hyg; 2021 Jan; 104(4):1278-1289. PubMed ID: 33534757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress to Eliminate Trachoma as a Public Health Problem in Amhara National Regional State, Ethiopia: Results of 152 Population-Based Surveys.
    Stewart AEP; Zerihun M; Gessese D; Melak B; Sata E; Nute AW; Astale T; Endeshaw T; Teferi T; Tadesse Z; Callahan EK; Chanyalew M; Gaudie B; Emerson PM; King JD; Nash SD
    Am J Trop Med Hyg; 2019 Dec; 101(6):1286-1295. PubMed ID: 31549612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facial cleanliness indicators by time of day: results of a cross-sectional trachoma prevalence survey in Senegal.
    Harding-Esch EM; Holland MJ; Schémann JF; Sissoko M; Sarr B; Butcher RMR; Molina-Gonzalez S; Andreasen AA; Mabey DCW; Bailey RL
    Parasit Vectors; 2020 Nov; 13(1):556. PubMed ID: 33203456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of effects of community intervention with antibiotics, facial cleanliness, and environmental improvement (A,F,E) in five districts of Ethiopia hyperendemic for trachoma.
    Ngondi J; Gebre T; Shargie EB; Adamu L; Teferi T; Zerihun M; Ayele B; King JD; Cromwell EA; Emerson PM
    Br J Ophthalmol; 2010 Mar; 94(3):278-81. PubMed ID: 19897474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trachoma prevalence remains below threshold in five districts after stopping mass drug administration: results of five surveillance surveys within a hyperendemic setting in Amhara, Ethiopia.
    Nash SD; Stewart AEP; Astale T; Sata E; Zerihun M; Gessese D; Melak B; Ayenew G; Ayele Z; Bayissasse B; Chanyalew M; Tadesse Z; Callahan EK
    Trans R Soc Trop Med Hyg; 2018 Dec; 112(12):538-545. PubMed ID: 30265355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of Mass Azithromycin Distribution for Ocular Chlamydia in a Trachoma Endemic Region of Ethiopia: A Cluster Randomized Trial.
    Lietman TM; Ayele B; Gebre T; Zerihun M; Tadesse Z; Emerson PM; Nash SD; Porco TC; Keenan JD; Oldenburg CE
    Am J Ophthalmol; 2020 Jun; 214():143-150. PubMed ID: 32171768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can corneal pannus with trachomatous inflammation--follicular be used in combination as an improved specific clinical sign for current ocular Chlamydia trachomatis infection?
    Derrick T; Holland MJ; Cassama E; Markham-David R; Nabicassa M; Marks M; Bailey RL; Last AR
    Parasit Vectors; 2016 Jan; 9():30. PubMed ID: 26812948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring Trachomatous Inflammation-Intense (TI) When Prevalence Is Low Provides Data on Infection With Chlamydia trachomatis.
    Zambrano AI; Muñoz BE; Mkocha H; Dize L; Gaydos CA; Quinn T; West SK
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):997-1000. PubMed ID: 28535271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions.
    Keenan JD; See CW; Moncada J; Ayele B; Gebre T; Stoller NE; McCulloch CE; Porco TC; Gaynor BD; Emerson PM; Schachter J; Lietman TM
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):235-40. PubMed ID: 22159017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of water, sanitation, and hygiene on the prevention of trachoma: a systematic review and meta-analysis.
    Stocks ME; Ogden S; Haddad D; Addiss DG; McGuire C; Freeman MC
    PLoS Med; 2014 Feb; 11(2):e1001605. PubMed ID: 24586120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial.
    Amza A; Kadri B; Nassirou B; Stoller NE; Yu SN; Zhou Z; Chin S; West SK; Bailey RL; Mabey DC; Keenan JD; Porco TC; Lietman TM; Gaynor BD;
    PLoS Negl Trop Dis; 2012; 6(4):e1586. PubMed ID: 22545165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma.
    Gwyn S; Nute AW; Sata E; Tadesse Z; Chernet A; Haile M; Zeru T; Bethea D; Laurent C; Callahan EK; Nash SD; Martin DL
    Am J Trop Med Hyg; 2021 Aug; 105(5):1362-1367. PubMed ID: 34398819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma.
    Keenan JD; Ayele B; Gebre T; Moncada J; Stoller NE; Zhou Z; Porco TC; McCulloch CE; Gaynor BD; Emerson PM; Schachter J; Lietman TM
    Clin Infect Dis; 2012 Jan; 54(2):253-6. PubMed ID: 22095569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.
    Yang JL; Hong KC; Schachter J; Moncada J; Lekew T; House JI; Zhou Z; Neuwelt MD; Rutar T; Halfpenny C; Shah N; Whitcher JP; Lietman TM
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):90-4. PubMed ID: 18689701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?
    Harding-Esch EM; Edwards T; Sillah A; Sarr I; Roberts CH; Snell P; Aryee E; Molina S; Holland MJ; Mabey DC; Bailey RL
    PLoS Negl Trop Dis; 2009 Dec; 3(12):e573. PubMed ID: 20027217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin.
    Edwards T; Harding-Esch EM; Hailu G; Andreason A; Mabey DC; Todd J; Cumberland P
    Trop Med Int Health; 2008 Apr; 13(4):556-65. PubMed ID: 18282237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlamydia on children and flies after mass antibiotic treatment for trachoma.
    Lee S; Alemayehu W; Melese M; Lakew T; Lee D; Yi E; Cevallos V; Donnellan C; Zhou Z; Chidambaram JD; Gaynor BD; Whitcher JP; Lietman TM
    Am J Trop Med Hyg; 2007 Jan; 76(1):129-31. PubMed ID: 17255240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ophthalmia neonatorum in a trachoma endemic area.
    Datta P; Frost E; Peeling R; Masinde S; Deslandes S; Echelu C; Wamola I; Brunham RC
    Sex Transm Dis; 1994; 21(1):1-4. PubMed ID: 8140482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precision of the Abbott RealTime Assay in the Detection of Ocular
    O'Brien KS; Chernet A; Moncada J; Schachter J; Emerson PM; Nash SD; Chanyalew M; Tadesse Z; Zhou Z; McCulloch CE; Lietman TM; Keenan JD
    Am J Trop Med Hyg; 2020 Jul; 103(1):234-237. PubMed ID: 32394877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chlamydial positivity of nasal discharge at baseline is associated with ocular chlamydial positivity 2 months following azithromycin treatment.
    Gower EW; Solomon AW; Burton MJ; Aguirre A; Muñoz B; Bailey R; Holland M; Makalo P; Massae P; Mkocha H; Mabey DC; West SK
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4767-71. PubMed ID: 17065486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.